01 1Cambrex Charles City, Inc.
01 1AZD9833
01 1U.S.A
NDC Package Code : 59116-7280
Start Marketing Date : 2023-06-13
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
42
PharmaCompass offers a list of Camizestrant API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Camizestrant manufacturer or Camizestrant supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Camizestrant manufacturer or Camizestrant supplier.
PharmaCompass also assists you with knowing the Camizestrant API Price utilized in the formulation of products. Camizestrant API Price is not always fixed or binding as the Camizestrant Price is obtained through a variety of data sources. The Camizestrant Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A AZD9833 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of AZD9833, including repackagers and relabelers. The FDA regulates AZD9833 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. AZD9833 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A AZD9833 supplier is an individual or a company that provides AZD9833 active pharmaceutical ingredient (API) or AZD9833 finished formulations upon request. The AZD9833 suppliers may include AZD9833 API manufacturers, exporters, distributors and traders.
click here to find a list of AZD9833 suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing AZD9833 as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for AZD9833 API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture AZD9833 as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain AZD9833 and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a AZD9833 NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of AZD9833 suppliers with NDC on PharmaCompass.
We have 1 companies offering AZD9833
Get in contact with the supplier of your choice:
